Immunogenicity, safety and clinical outcomes of the SARS-CoV-2 BNT162b2 vaccine in adolescents with type 1 diabetes

Immunogenicity, safety and clinical outcomes of the SARS-CoV-2 BNT162b2 vaccine in adolescents with type 1 diabetes

IntroductionThe mRNA-based BNT162b2 (Pfizer-BioNTech) vaccine has been shown to elicit robust systemic immune response and confer substantial protection against the severe coronavirus disease (COVID-19), with a favorable safety profile in adolescents. However, no data exist regarding immunogenicity,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hamdi Cihan Emeksiz (Author), Merve Nur Hepokur (Author), Sibel Ergin Şahin (Author), Banu Nursoy Şirvan (Author), Burçin Çiçek (Author), Aşan Önder (Author), Metin Yıldız (Author), Derya Karaman Aksakal (Author), Aysun Bideci (Author), Hüsnü Fahri Ovalı (Author), Ferruh İşman (Author)
Format: Book
Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items